Black Diamond Therapeutics Ownership | Who Owns Black Diamond Therapeutics?
Black Diamond Therapeutics Ownership Summary
Black Diamond Therapeutics is owned by 85.96% institutional investors, 2.26% insiders, and 11.78% retail investors. T. rowe price investment management is the largest institutional shareholder, holding 20.58% of BDTX shares. BB Biotech AG Ord is the top mutual fund, with 15.07% of its assets in Black Diamond Therapeutics shares.
BDTX Ownership Benchmark
| Type | Name | % Inst | % Insiders | % Retail |
|---|---|---|---|---|
| Stock | Black Diamond Therapeutics | 85.96% | 2.26% | 11.78% |
| Sector | Healthcare Stocks | 49.73% | 8.84% | 41.43% |
| Industry | Biotech Stocks | 47.04% | 8.74% | 44.21% |
Institutional Shareholders
Top Institutional Shareholders by Total Shares
| Holder | Shares | % Holding | Value |
|---|---|---|---|
| T. rowe price investment management | 10.66M | 20.58% | $49.67M |
| Bellevue group | 8.52M | 16.44% | $39.69M |
| Nea management company | 4.45M | 8.59% | $20.73M |
| Blackrock | 3.22M | 6.21% | $14.99M |
| Vanguard group | 2.13M | 4.11% | $9.93M |
| Vestal point capital, lp | 2.10M | 4.05% | $9.79M |
| Tang capital management | 1.60M | 3.09% | $7.47M |
| Artal group | 1.05M | 2.02% | $4.88M |
| Geode capital management | 842.43K | 1.63% | $3.93M |
| Price t rowe associates inc /md/ | 813.07K | 1.57% | $3.79M |
Top Institutional Shareholders by % of Total Assets
| Holder | Shares | % Assets | Value |
|---|---|---|---|
| Nea management company | 4.45M | 1.56% | $20.73M |
| Tang capital management | 1.60M | 0.76% | $7.47M |
| Vestal point capital, lp | 2.10M | 0.73% | $9.79M |
| Bellevue group | 8.52M | 0.65% | $39.69M |
| Artal group | 1.05M | 0.12% | $4.88M |
| Boxer capital | 506.00K | 0.12% | $2.36M |
| Newtyn management | 95.00K | 0.08% | $442.70K |
| Kennedy capital management | 703.28K | 0.07% | $3.28M |
| Cornercap investment counsel | 48.11K | 0.04% | $224.19K |
| T. rowe price investment management | 10.66M | 0.03% | $49.67M |
Top Buyers
| Holder | Shares | % Assets | Change |
|---|---|---|---|
| T. rowe price investment management | 10.66M | 0.03% | 3.93M |
| Vestal point capital, lp | 2.10M | 0.73% | 2.10M |
| Blackrock | 3.22M | 0.00% | 1.84M |
| Price t rowe associates inc /md/ | 813.07K | 0.00% | 813.07K |
| Invesco | 712.38K | 0.00% | 712.38K |
Top Sellers
| Holder | Shares | % Assets | Change |
|---|---|---|---|
| Ra capital management | - | - | -3.53M |
| Laurion capital management lp | - | - | -878.29K |
| Ally bridge group (ny) | - | - | -835.00K |
| Blue owl capital lp | - | - | -695.00K |
| Stempoint capital lp | - | - | -674.20K |
New Positions
| Holder | Shares | % Assets | Change | Value |
|---|---|---|---|---|
| Vestal point capital, lp | 2.10M | 0.73% | 2.10M | $9.79M |
| Price t rowe associates inc /md/ | 813.07K | 0.00% | 813.07K | $3.79M |
| Invesco | 712.38K | 0.00% | 712.38K | $3.32M |
| Nuveen asset management | 122.00K | 0.00% | 122.00K | $568.53K |
| Bank of new york mellon | 108.96K | 0.00% | 108.96K | $507.75K |
Sold Out
| Holder | Change |
|---|---|
| Tsfg | -100.00 |
| Federated hermes | -107.00 |
| Newbridge financial services group | -500.00 |
| Macquarie group | -1.18K |
| Palumbo wealth management | -10.24K |
Institutional Ownership Trends
| Date | Holdings | Change % | Shares | Change % | Ownership | Change % | Increased Position | Change % | Decreased Position | Change % |
|---|---|---|---|---|---|---|---|---|---|---|
| Sep 30, 2024 | 113 | 21.51% | 48,573,437 | 4.44% | 85 | 1.07% | 67 | 19.64% | 20 | 11.11% |
| Jun 30, 2024 | 93 | 4.49% | 46,507,345 | 18.77% | 89 | 1.13% | 56 | 12.00% | 18 | -18.18% |
| Mar 31, 2024 | 89 | 15.58% | 39,156,127 | 2.72% | 89 | 1.59% | 50 | 31.58% | 22 | 10.00% |
| Dec 31, 2023 | 77 | - | 38,119,952 | 2.48% | 74 | 0.72% | 38 | - | 20 | 17.65% |
| Sep 30, 2023 | 77 | -3.75% | 37,195,825 | -8.55% | 101 | 0.82% | 38 | -19.15% | 17 | 13.33% |
Top Mutual Funds Shareholders
| Holder | Shares | % Holding | Change |
|---|---|---|---|
| BB Biotech AG Ord | 8.52M | 15.07% | - |
| T. Rowe Price Small-Cap Value | 2.56M | 4.53% | -42.71K |
| T. Rowe Price US Small-Cap Core Equity | 2.51M | 4.44% | 14.02K |
| T. Rowe Price Small-Cap Stock | 2.51M | 4.44% | 8.76K |
| Vanguard Total Stock Mkt Idx Inv | 1.33M | 2.35% | - |
| T. Rowe Price Instl Small-Cap Stock | 1.24M | 2.19% | 6.80K |
| T. Rowe Price U.S. SC Value Eq Tr-Z | 1.23M | 2.19% | 30.73K |
| T. Rowe Price U.S. SC Core Eq Tr-Z | 1.21M | 2.14% | 41.89K |
| iShares Russell 2000 ETF | 1.03M | 1.82% | -2.31K |
| BlackRock Health Sciences Term Trust | 866.00K | 1.53% | 32.45K |
Recent Insider Transactions
| Date | Name | Role | Activity | Value |
|---|---|---|---|---|
| Aug 28, 2024 | Versant Venture Capital VI, L.P. | - | Sell | $1.40M |
| Oct 17, 2023 | BIOTECH GROWTH N V | - | Buy | $934.08K |
| Jul 05, 2023 | RA CAPITAL MANAGEMENT, L.P. | - | Buy | $4.68M |
| Jul 05, 2023 | Behbahani Ali | - | Buy | $5.00M |
| Jun 30, 2023 | BIOTECH GROWTH N V | - | Buy | $5.00M |
Insider Transactions Trends
| Date | Buy | Sell |
|---|---|---|
| 2024 Q3 | - | 1 |
| 2024 Q2 | - | - |
| 2024 Q1 | - | - |
| 2023 Q4 | 1 | - |
| 2023 Q3 | 2 | - |
BDTX Ownership FAQ
Try Tickergate Pro Free
Customize Everything. 100% Flexibility. Fast and Easy to Use (No code or Excel Needed)
Customize your own personal stocks lists, views and charts
Choose from hundreds of fields, up to 15 years of history
Conduct deep comparison analysis
Discover trending investment themes
Find your next best investment
Research stocks using tools